SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Wells Fargo Maintains Conmed at Equal-Weight, Raises Target to $49

Wells Fargo maintained its Equal-Weight rating on Conmed and raised its price target to $49 from $46.

CNMD

Story updates

02:16:01 PM UTC
SquawkNews
Conmed Price Target Raised to $49.00/Share From $46.00 by Wells Fargo

Related stories